Autoimmune lymphoproliferative syndrome type III, an indefinite disorder.
about
How I treat autoimmune lymphoproliferative syndromeUse of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS)Dual Role of Fas/FasL-Mediated Signal in Peripheral Immune Tolerance.
P2860
Autoimmune lymphoproliferative syndrome type III, an indefinite disorder.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Autoimmune lymphoproliferative syndrome type III, an indefinite disorder.
@ast
Autoimmune lymphoproliferative syndrome type III, an indefinite disorder.
@en
Autoimmune lymphoproliferative syndrome type III, an indefinite disorder.
@nl
type
label
Autoimmune lymphoproliferative syndrome type III, an indefinite disorder.
@ast
Autoimmune lymphoproliferative syndrome type III, an indefinite disorder.
@en
Autoimmune lymphoproliferative syndrome type III, an indefinite disorder.
@nl
prefLabel
Autoimmune lymphoproliferative syndrome type III, an indefinite disorder.
@ast
Autoimmune lymphoproliferative syndrome type III, an indefinite disorder.
@en
Autoimmune lymphoproliferative syndrome type III, an indefinite disorder.
@nl
P2093
P2860
P1433
P1476
Autoimmune lymphoproliferative syndrome type III, an indefinite disorder.
@en
P2093
Thielemans K
van der Werff ten Bosch J
P2860
P304
P356
10.3109/10428190109060341
P577
2001-05-01T00:00:00Z